Chemitope Glycopeptide

Chemitope Glycopeptide is a small biotechnology company based in Brooklyn, New York. With three employees, the company generates $2.5 million in annual revenue. Chemitope Glycopeptide specializes in the chemical synthesis of glycopeptides, complex molecules that play a crucial role in biological processes. These glycopeptides are produced for research and clinical development, particularly in the fields of cancer and infectious diseases. The company's expertise in carbohydrate and peptide chemistry allows for precise control over the structure of the glycopeptides, ensuring high homogeneity and quality. Chemitope's research and development efforts are focused on utilizing glycosylation, the process of attaching sugar molecules to proteins, as a target for therapeutic and preventative vaccines. They aim to develop glycopeptide immunogens that can effectively stimulate the immune system against cancer and infectious agents. Beyond research, Chemitope provides comprehensive chemical synthesis and pre-clinical manufacturing support to academic institutions, biotech companies, and pharmaceutical firms. For more information about Chemitope Glycopeptide and its services, please visit their website at chemitopeglycopeptide.com.